Man Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,281
Closed -$372K 2360
2025
Q1
$372K Buy
+21,281
New +$359K ﹤0.01% 1884
2022
Q1
Sell
-59,820
Closed -$810K 2345
2021
Q4
$810K Buy
59,820
+42,020
+236% +$595K ﹤0.01% 1389
2021
Q3
$262K Buy
+17,800
New +$301K ﹤0.01% 1680
2021
Q2
Sell
-40,700
Closed -$707K 2081
2021
Q1
$707K Sell
40,700
-323,200
-89% -$5.68M ﹤0.01% 1389
2020
Q4
$6.32M Buy
363,900
+242,500
+200% +$3.87M 0.03% 667
2020
Q3
$1.67M Buy
121,400
+100,271
+475% +$1.47M 0.01% 1246
2020
Q2
$305K Sell
21,129
-34,470
-62% -$453K ﹤0.01% 1537
2020
Q1
$607K Buy
+55,599
New +$1.03M ﹤0.01% 1238

Other funds holding SBRA

Man Group's SBRA Position: Q2 2025 in Review

Man Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 21,281 shares — an estimated $372K sold.

Man Group first reported a position in SBRA in Q1 2020 and held it in 8 quarters. The position peaked at $6.32M in Q4 2020. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Man Group reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Man Group sold 21,281 Sabra Healthcare REIT shares in Q2 2025, an estimated $372K.
  • Man Group first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 8 quarters.
  • Man Group's Sabra Healthcare REIT position peaked at $6.32M in Q4 2020.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.